FGFR2 and gastrointestinal stromal tumor: Given that FGFR2 was overexpressed in IM-resistant GIST T-1R cells [16], we sought to examine whether the knockdown of FGFR2 will sensitize tumor cells to DNA-topoisomerase II inhibitors due to attenuation of HR-mediated DNA repair.